Cargando…
The Baseline Serum IgG4/IgG3 Ratio Might be a Suitable Marker for Predicting Favorable Treatment Response in Patients With Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis
Autor principal: | Kwok, Seung-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Rheumatology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324890/ https://www.ncbi.nlm.nih.gov/pubmed/37476016 http://dx.doi.org/10.4078/jrd.2021.28.2.53 |
Ejemplares similares
-
Treatment Response to Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis With a Focus on IgG4/IgG3 Serum Concentration Ratio
por: Choi, Su Jin, et al.
Publicado: (2021) -
Unilateral Leg Edema and Hydronephrosis in IgG4-Related Retroperitoneal Fibrosis
por: Kobayashi, Takahiro, et al.
Publicado: (2023) -
Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis
por: Wallwork, Rachel, et al.
Publicado: (2018) -
Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis
por: Wang, Kunkun, et al.
Publicado: (2021) -
Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)